Peritoneal (Metastatic) Cancer
Oncology·MeSH: Neoplasm Metastasis
Prevalence
30.0 / 100K
0 drugs in development·0 companies·1 clinical trial
Frequently asked questions
How many clinical trials target Peritoneal (Metastatic) Cancer?
There are 1 clinical trial targeting Peritoneal (Metastatic) Cancer tracked by BioSniper.
What is the prevalence of Peritoneal (Metastatic) Cancer?
The estimated prevalence of Peritoneal (Metastatic) Cancer is approximately 30.0 per 100,000 population.
Deep-dive into Peritoneal (Metastatic) Cancer
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis